AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SCOTTSDALE, ARIZ. -- Postprocedure use of a GnRH agonist did not enhance the effects of uterine artery embolization in the treatment of fibroids in a small prospective, randomized trial.
Given these results, physicians should pick one treatment or the other but should not bother combining them, study investigator Dr. George A. Vilos said at an international congress on uterine fibroids sponsored by the American Association of Gynecologic Laparoscopists.
It's well known that GnRH agonists temporarily shrink uterine fibroids by about 50% after 3 months of treatment, and that fibroids grow back within a few months once the drug is stopped.
Uterine artery embolization (UAE) has been shown to permanently shrink fibroids by about 50%.
Investigators wondered whether combining the two treatments might make a fibroid completely disappear, at least temporarily.
In the study, 26 women with symptomatic uterine fibroids underwent UAE with polyvinyl alcohol particles as the primary embolic agent. Fourteen randomly chosen patients received 10.8 mg of the GnRH agonist goserelin injected 24 hours after the ...